The Sensex has been confined to a narrow range of 90 points between an intra-day high of 28,899 and a low of 28,810, while the Nifty has been stuck between 8781 on the higher side and 8758 at the lower end, as the gains in the oil and gas space have been offset by losses on the pharma counters. The benchmark indices had gained in the previous five straight sessions hitting one-month closing highs; with the Nifty ending comfortably above the 8750 mark in Thursday's session on the back of India's outlook upgrade by Moody's.
However, the broader space is continuing its recent outperformance vis-a-vis the benchmark indices, with the midcap index quoting at 11,125, higher by 76 points or 0.6% and the smallcap index placed at 11802, up 85 points or 0.7%.
The markets will keep an eye on the Index of Industrial Production (IIP) numbers to be unveiled in the course of the day.
ASIAN MARKETS
Japan's Nikkei share average slipped on Friday when the initial euphoria as it topped the psychological milestone of 20,000 was quickly taken over by selling to lock in the past few months' solid gains.
The Nikkei fell 0.2% to 19,897.97, reversing its course after having risen above the 20,000 mark for the first time in 15 years.
The rally has been driven by many factors, including hopes of higher shareholder returns, rise in corporate earnings, recovery in domestic consumption and more share buying, both real and imagined, by Japanese public investors.
The market expects Japanese corporate earnings to rise 10 to 15% this year, but with the Nikkei already up 14% so far this year, some investors see limited justification to chase more gains.
SECTORS & BUZZING STOCKS
The oil space continues to hog the limelight on the BSE, with Oil India, BPCL and Oil India gaining about a per cent each. However, RIL is trading flat at Rs 894 after soaring by almost 4% in the previous session on reports that the company had discovered massive gas reserves at MJ-1 block in its KG-D6 basin.
On the other hand, the pharma stocks are seeing some selling pressure on the BSE post their recent gains. Lupin, Cipla, Cadilla and Dr Reddy's have shed anywhere between 1% and 2% each.
The BSE banking index is also under strain at 21,614, down 0.3%. The index had surged more than 1% in Thursday's session of trade after Moody's Investors Service changed India's outlook to 'positive' from 'stable' earlier and affirmed 'Baa3' credit rating. HDFC Bank, ICICI Bank and Axis Bank have lost upto a per cent each. SBI has, however, bucked the weak trend in the sector, adding more than a per cent at Rs 283.
Among individual names, Sesa Sterlite has rallied by 2% at Rs 199 to top the gainers list on the BSE. The other prominent gainers are SBI, Bhel and Infosys, which have added between 1% and 2% each.
On the other hand, Cipla tops the loser's list on the BSE, shedding 1.7% at Rs 706. Hindalco, HDFC Bank and ITC have lost around a per cent each.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)